Stay updated on Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new page revision tag v3.5.4 was added, replacing the previous v3.5.3. This reflects an update to the page's revision history rather than changes to the study's content or results.
    Difference
    0.0%
    Check dated 2026-05-15T16:40:49.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    No textual changes were recorded in the provided data; the page content appears unchanged according to the supplied changes.
    Difference
    0.1%
    Check dated 2026-05-08T12:34:48.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number has been updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T05:53:05.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:28:20.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    No additions or deletions are present for this page. The content remains unchanged.
    Difference
    0.1%
    Check dated 2026-04-09T21:01:23.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Added 'Squamous cell carcinoma of the head and neck' as a condition listing and included a new Resources section linking the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T14:59:25.000Z thumbnail image

Stay in the know with updates to Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.